Búsqueda de Publicación - Prisma - Unidad de Bibliometría

Publicaciones en la fuente AIDS

Tipo Año Título Fuente
Artículo2023Hepatic steatosis after switching to integrase inhibitor-based regimens does not parallel short-term weight gainAIDS
Letter2023Response to: Reply to: Anti-CD4 autoantibodies in immunological nonresponder people living with HIV: cause of CD4+ T cell depletion?AIDS
Artículo2022Anti-CD4 autoantibodies in immunological nonresponder people with HIV: cause of CD4 + T-cell depletion?AIDS
Artículo2022Tenofovir disoproxil fumarate/emtricitabine and severity of coronavirus disease 2019 in people with HIV infectionAIDS
Artículo2021Kinetics of emergence of liver complications in HCV-infected patients and advanced fibrosis, with and without HIV-coinfection, after SVR.AIDS
Artículo2020CD300a identifies a CD4+ memory T cell subset with a higher susceptibility to HIV-1 infectionAIDS
Artículo2020Impact of HIV on the survival of hepatocellular carcinoma in hepatitis C virus-infected patientsAIDS
Artículo2019HIV infection does not increase the risk of liver complications in hepatitis C virus-infected patient with advanced fibrosis, after sustained virological response with direct-acting antiviralsAIDS
Artículo2019Low performance of ultrasound surveillance for the diagnosis of hepatocellular carcinoma in HIV-infected patientsAIDS
Artículo2019Treatment outcome in dually HIV-1 and HIV-2 coinfected patients living in SpainAIDS
Artículo2018Hepatocellular carcinoma after sustained virological response with interferon-free regimens in HIV/hepatitis C virus-coinfected patientsAIDS
Revisión2017Human T-lymphotropic virus type 1 infection and disease in SpainAIDS
Artículo2017Liver stiffness predicts variceal bleeding in HIV/HCV-coinfected patients with compensated cirrhosisAIDS
Artículo2017Real-life experience with sorafenib for the treatment of hepatocellular carcinoma in HIV-infected patientsAIDS
Letter2015IFNL4 rs368234815 polymorphism is associated with innate resistance to HIV-1 infectionAIDS
Artículo2015Impact of genetic polymorphisms associated with nonalcoholic fatty liver disease on HIV-infected individualsAIDS
Artículo2014Cellular HIV reservoir replenishment is not affected by blip or intermittent viremia episodes during darunavir/ritonavir monotherapyAIDS
Artículo2014HIV drug resistance detected during low-level viraemia is associated with subsequent virologic failureAIDS
Artículo2014HIV/hepatitis C virus-coinfected patients who achieved sustained virological response are still at risk of developing hepatocellular carcinomaAIDS
Artículo2014Incidence and natural history of hepatitis E virus coinfection among HIV-infected patientsAIDS
Artículo2014Microbial translocation and T cell activation are not associated in chronic HIV-infected childrenAIDS
Artículo2014Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countriesAIDS
Artículo2014Prevalence and factors associated with liver steatosis as measured by transient elastography with controlled attenuation parameter in HIV-infected patientsAIDS
Artículo2013Endoplasmic reticulum aminopeptidase 2 haplotypes play a role in modulating susceptibility to HIV infectionAIDS
Artículo2013Liver stiffness measurement versus liver biopsy to predict survival and decompensations of cirrhosis among HIV/hepatitis C virus-coinfected patientsAIDS
Artículo2013The IL28B effect on hepatitis C virus kinetics among HIV patients after the first weeks of pegylated-interferon/ribavirin treatment varies according to hepatitis C virus-1 subtypeAIDS
Artículo2013The impact of interleukin 28B rs12979860 single nucleotide polymorphism and liver fibrosis stage on response-guided therapy in HIV/HCV-coinfected patientsAIDS
Artículo2013Variations at multiple genes improve interleukin 28B genotype predictive capacity for response to therapy against hepatitis C infectionAIDS
Artículo2012Differences in the causes of death of HIV-positive patients in a cohort study by data sources and coding algorithmsAIDS
Artículo2012Genetic variability at the TREX1 locus is not associated with natural resistance to HIV-1 infectionAIDS
Artículo2012Hepatitis C virus genotype 4 responds better to pegylated interferon with ribavirin than genotype 1 in HIV-infected patientsAIDS
Artículo2012LDLr genotype modifies the impact of IL28B on HCV viral kinetics after the first weeks of treatment with PEG-IFN/RBV in HIV/HCV patientsAIDS
Artículo2012The effect of efavirenz versus nevirapine-containing regimens on immunologic, virologic and clinical outcomes in a prospective observational studyAIDS
Artículo2011Association between IL28B gene polymorphisms and plasma HCV-RNA levels in HIV/HCV-co-infected patientsAIDS
Artículo2011Impact of IL28B polymorphisms on response to peginterferon and ribavirin in HIV-hepatitis C virus-coinfected patients with prior nonresponse or relapseAIDS
Artículo2011Low-density lipoprotein receptor genotyping enhances the predictive value of IL28B genotype in HIV/hepatitis C virus-coinfected patientsAIDS
Artículo2010Ability of treatment week 12 viral response to predict long-term outcome in genotype 1 hepatitis C virus/HIV coinfected patientsAIDS
Artículo2010Clinical presentation and prognosis of the 2009 H1N1 influenza A infection in HIV-1-infected patients: a Spanish multicenter studyAIDS
Artículo2010The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individualsAIDS
Artículo2008Baseline serum low-density lipoprotein cholesterol levels predict response to hepatitis C virus therapy in HIV/hepatitis C virus coinfected patientsAIDS
Artículo2008Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and two nucleosides for maintenance therapy of HIVAIDS
Artículo2007Changes in the incidence of tuberculosis in a cohort of HIV-seroconverters before and after the introduction of HAARTAIDS
Letter2006Stopping antiretroviral therapy in 'prematurely treated' HIV-1-infected children with full viral supression is safeAIDS
Artículo2006Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver diseaseAIDS
Letter2005A case-control study of HIV patients with the K65R mutation in the reverse transcriptase gene with virological failure [2]AIDS
Artículo2004Effect of antiretroviral drugs on liver fibrosis in HIV-infected patients with chronic hepatitis C: harmful impact of nevirapineAIDS
Letter2004Prevalence of non-significant liver fibrosis and rate of fibrosis progression in HIV/hepatitis C virus-co-infected patients: still a role for liver biopsy?AIDS
Letter2004Relapsing blepharitis in patients under highly active antiretroviral therapy including indinavirAIDS
Artículo2003Effectiveness of highly active antiretroviral therapy in Spanish cohorts of HIV seroconverters: differences by transmission categoryAIDS
Artículo2003Endogenous IL-7 is associated with increased thymic volume in adult HIV-infected patients under highly active antiretroviral therapyAIDS
Artículo2002Epidemiological trends of HIV infection in Spain: preventative plans have to be oriented to new target populations (Spanish VACH Cohort)AIDS
Artículo2001Changes in the rate of genotypic resistance to antiretroviral drugs in SpainAIDS
Letter2001Cidofovir added to highly active antiretroviral therapy in AIDS-associated progressive multifocal leukoencephalopathyAIDS
Artículo2001Drug resistance in patients experiencing early virological failure under a triple combination including indinavirAIDS
Letter2001Efavirenz plasma concentrations and efficiencyAIDS
Artículo2001Structural normalization of the lymphoid tissue in asymptomatic HIV-infected patients after 48 weeks of potent antiretroviral therapyAIDS
Artículo2000Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in SpainAIDS
Artículo1999Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimoniate with amphotericin BAIDS
Resumen congreso1998Antiviral efficacy and tolerance of a quadruple antiretroviral therapy including indinavir plus saquinavir in asymptomatic HIV-infected patients with CD4+ counts ≥ 500 cells/μLAIDS
Resumen congreso1998Factors associated with survival in HIV patients with very low CD4 counts.AIDS
Resumen congreso1998High frequency of serious side effects of meglumine antimoniate given at the currently recommended dose for the treatment of visceral leishmaniasis in HIV-1 infected patientsAIDS
Artículo1998Prevalence of genotypic resistance to nucleoside analogues in antiretroviral-naive and antiretroviral-experienced HIV-infected patients in SpainAIDS
Artículo1998Short-term evolution of HIV-1 viraemia and CD4+ cell counts in patients who have a primary mutation to zidovudineAIDS
Letter1997Foscarnet and AIDS-associated Kaposi's sarcomaAIDS
Letter1997Increase in the frequency of mutation at codon 215 associated with zidovudine resistance in HIV-1-infected antiviral-naive patients from 1989 to 1996AIDS
Letter1997Rhodococcus or mycobacterium? An example of misdiagnosis in HIV infection.AIDS
Letter1996Cytokine network and HIV syncytium-inducing phenotype shiftAIDS
Letter1996Disseminated papular eruption caused by Serratia marcescens: A new cutaneous manifestation in HIV-positive patients [8]AIDS
Letter1994Fatal Psychrobacter immobilis infection in a patient with AIDSAIDS
Letter1993An easy and quick method for the diagnosis of visceral leishmaniasis in HIV-1-infected individuals AIDS
Letter1993Misdiagnosis of HTLV-II infection using HTLV-I screening assaysAIDS
Artículo1992HIV-1 infection among non-intravenous drug user female prostitutes in Spain. No evidence of evolution to pattern IIAIDS
Letter1992HIV-2 infection in Spain: Report of the 1st 34 casesAIDS
Artículo1992Pharmacokinetics of zidovudine in end-stage renal disease: Influence of haemodialysisAIDS
Artículo1992Visceral leishmaniasis in HIV-1-infected individuals: A common opportunistic infection in Spain?AIDS